Back to top

CONVERTIBLE PROMISSORY NOTE

Convertible Promissory Note

CONVERTIBLE PROMISSORY NOTE | Document Parties: Advanced Cell Technology Inc You are currently viewing:
This Convertible Promissory Note involves

Advanced Cell Technology Inc

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: CONVERTIBLE PROMISSORY NOTE
Date: 7/15/2008
Industry: Biotechnology and Drugs     Sector: Healthcare

CONVERTIBLE PROMISSORY NOTE, Parties: advanced cell technology inc
50 of the Top 250 law firms use our Products every day

Exhibit 10.10

 

CONVERTIBLE PROMISSORY NOTE
$1,200,000 PLUS INTEREST DUE & PAYABLE
DOCUMENT B-02152008

 

THIS NOTE AND THE SHARES ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED THIS NOTE AND THE SHARES ISSUABLE UPON CONVERSION OF THIS NOTE MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT OR APPLICABLE EXEMPTION OR SAFE HARBOR PROVISION.

 

FOR VALUE RECEIVED, on the Effective Date, as defined below, Advanced Cell Technology Inc. as Obligor (“Borrower,” or “Obligor”), hereby promises to pay to the Lender (“Lender” or “ Holder”), as defined below, the Principal Sum, as defined below, along with the Interest Rate, as defined below, according to the terms herein

 

The “Effective Date” shall be;

 

February 15, 2008

 

 

 

The “Lender” shall be:

 

JMJ Financial / Its Principal, or Its Assignees

 

 

 

The “Principal Sum” shall be:

 

$1,200,000 (one million two hundred thousand) US Dollars or so much as may be paid towards the balance of Document
C-02152008; Subject to the following; accrued, unpaid interest shall be added to the Principal Sum.

 

 

 

The “Consideration” shall be:

 

$1,000,000 (one million) dollars in the form of the Secured & Collateralized Promissory Note Document C-02152008 (including Security & Collateral Agreement).

 

 

 

The “Interest Rate” shall be:

 

10% one-time interest charge on the Principal Sum.  No interest or principal payments are required until the Maturity Date, but both principal and interest may be included in conversion prior to maturity date.

 

 

 

The “Conversion Price” shall be the following price:

 

As applied to the Conversion Formula set forth in 22, the lesser of (a) $0 38 or (b) 80% (eighty percent) of the average of the 3 (three) lowest trade prices in the 20 trading days previous to the conversion; as applies to Advanced Cell Technology Inc. voting common stock.

 

 

 

The “Maturity Date” is the date upon which the Principal Sum of this Note, as well as any unpaid interest shall be due and payable, and that date shall be:

 

February 15, 2010

 

 

 

The “Prepayment Terms” shall be:

 

See Section 1.2

 



 

ARTICLE 1 PAYMENT-RELATED PROVISIONS

 

1.1. Interest Rate. Subject to the Holder’s right to convert, interest payable on this Note will accrue interest at the Interest Rate and shall be applied to the Principal Sum.

 

1.2. Prepayment Terms. Prepayment is permitted as set forth under the follow options. For the first 150 days after the Effective Date, the maximum prepayment amount is $500,000 as set forth below. From and after the 150 th day from the Effective Date, prepayment may be made in full as set forth below.

 

(a) Prepayment By Cash or Other Negotiated Form. Prepayment is permitted at any time by payment in the form of either of the following: (1) cash, or (2) other negotiated form of payment mutually agreed to in writing. In this event, the original issue discount of $200,000 and the one-time interest charge of $60,000 will be struck from the principal balance of this Note.

 

(b) Prepayment By Surrender of Document C-02152008. Prepayment is permitted by surrender of the Secured & Collatetalized Promissory Note Document C-02152008, as set forth below.

 

(i)    Prior to Holder Making Payments To Document C-02152008, Prepayment by surrender of Document C-02152008 is permitted at any time prior to Holder making payment towards the outstanding balance of Document C-02152008. In this event, this Document B-02152008 original issue discount of $200,000 and the one-time interest charge of $60,000 will be struck from the principal balance of this Note Document B-02152008. Concurrently, all interest charges and all other charges will be struck from Document C-02152008.

 

(ii)   After Holder Making Payments To Document C-02152008. Prepayment by surrender of Document C-02152008 is permitted at any time after Holder making payment towards the outstanding balance of Document C-02152008. In this event, the remaining original issue discount premium (OIDP) will be proportionately adjusted for this Document B-02152008 at the rate of 20%, and the remaining one-time interest charge will be proportionately adjusted at the rate of 10%. The remaining balance is payable in cash or convertible into stock as set forth in this agreement. This prepayment scenario is demonstrated in the attached Prepayment Adjustment Example.

 

ARTICLE 2 CONVERSION RIGHTS

 

The Holder will have the right to convert the Principal Sum and accrued interest under this Note into Shares of the Borrower’s Common Stock as set forth below.

 

2.1 Conversion Rights and Cashless Exercise.  Subject to the terms set forth in Section 2.7, the Holder will have the right at its election from and after the Effective Date, and then at any time, to convert all or part of the outstanding and unpaid Principal Sum and accrued interest into shares of fully paid and nonassessable shares of common stock of Advanced Cell Technology Inc. (as such stock exists on the date of issuance of this Note, or any shares of capital stock of Advanced Cell Technology Inc.  into which such stock is hereafter changed or

 



 

reclassified, the “Common Stock”) as per the Conversion Formula set forth in Section 2.2. Any such conversion shall be cashless, and shall not require further payment from Holder. Unless otherwise agreed in writing by both the Borrower and the Holder, at no time will the Holder convert any amount of the Note into common stock that would result in the Holder owning more than 4.99% of the common stock outstanding of Advanced Cell Technology Inc. Shares from any such conversion will be delivered to Holder within 2 (two) business days of conversion notice delivery (see 3.1) via 10:30am priority overnight delivery service (see Section 2.6)

 

2.2. Conversion Formula. The number of shares issued through conversion is the conversion amount divided by the conversion price.

 

# Shares = Conversion Amount

Conversion Price

 

2.3 This Section 2.3 intentionally left blank.

 

2.4. Adjustment Upon Dilutive Offers, Agreements, or Sales. If the Borrower, at any time while this Note is outstanding, enters into an agreement under which it issues or agrees to issue either its common stock, options, or warrants to purchase or convert to its common





 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more